Beyond GLP-1s: The next chapter of obesity care

A new commentary in the journal Gastroenterology updates the POWER framework to address obesity care in the era of GLP-1 medications. The paper emphasizes a multidisciplinary approach, integrating medication with endoscopic therapies and lifestyle management.
Why it matters
As obesity rates rise, shifting from medication-only treatments to comprehensive, personalized care models is critical for long-term patient health.
by American Gastroenterological Association
The content is based on medical research and professional guidelines, presented with scientific objectivity.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in